Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 47.30
-0.70 (-1.46%)
Aug 19, 2026, 1:30 PM CST
Orient EuroPharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,164 | 3,886 | 4,181 | 3,374 | 3,140 | 3,153 | |
Market Cap Growth | -8.22% | -7.05% | 23.91% | 7.46% | -0.41% | -24.43% |
Enterprise Value | 6,753 | 5,718 | 8,267 | 7,274 | 6,427 | 5,292 |
Last Close Price | 48.00 | 41.07 | 43.40 | 34.33 | 31.94 | 31.28 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 23.44 | - | 26.24 |
Forward PE | - | 17.63 | 17.63 | 17.63 | 17.63 | 17.63 |
PS Ratio | 0.91 | 0.85 | 0.95 | 0.74 | 0.66 | 0.66 |
PB Ratio | 0.62 | 0.53 | 0.72 | 0.81 | 0.91 | 0.91 |
P/TBV Ratio | 0.74 | 0.62 | 0.82 | 0.97 | 1.09 | 1.10 |
P/OCF Ratio | - | - | - | 52.18 | - | 40.61 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.47 | 1.24 | 1.88 | 1.58 | 1.36 | 1.11 |
EV/EBITDA Ratio | - | - | 53.87 | 30.85 | 913.23 | 87.72 |
EV/EBIT Ratio | - | - | - | 103.01 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.50 | 0.44 | 0.73 | 1.16 | 1.46 | 1.22 |
Debt / EBITDA Ratio | - | - | 21.15 | 16.88 | 112.21 | 44.25 |
Net Debt / Equity Ratio | 0.22 | 0.16 | 0.45 | 0.71 | 0.92 | 0.63 |
Net Debt / EBITDA Ratio | -24.71 | -7.57 | 17.07 | 12.49 | 447.95 | 36.16 |
Net Debt / FCF Ratio | -2.95 | -2.52 | -11.90 | -84.82 | -3.67 | -1.47 |
Asset Turnover | 0.39 | 0.39 | 0.39 | 0.43 | 0.48 | 0.54 |
Inventory Turnover | 2.26 | 2.16 | 2.10 | 2.00 | 2.26 | 2.15 |
Quick Ratio | 0.93 | 1.00 | 0.75 | 0.73 | 0.69 | 0.82 |
Current Ratio | 1.38 | 1.48 | 1.20 | 1.14 | 1.10 | 1.22 |
Return on Equity (ROE) | -5.43% | -7.29% | -4.63% | 4.45% | -8.57% | 2.02% |
Return on Assets (ROA) | -1.16% | -1.63% | -0.04% | 0.42% | -0.94% | -0.68% |
Return on Invested Capital (ROIC) | -2.59% | -3.66% | -0.09% | 0.68% | -2.44% | -1.74% |
Return on Capital Employed (ROCE) | -2.50% | -3.30% | -0.10% | 1.00% | -2.30% | -1.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -10.53% | -14.60% | -6.79% | 4.27% | -9.90% | 3.81% |
FCF Yield | -12.22% | -11.99% | -5.27% | -1.03% | -27.32% | -47.10% |
Dividend Yield | 8.26% | 9.74% | 2.30% | 2.91% | - | 2.72% |
Payout Ratio | - | - | - | - | - | 108.28% |
Buyback Yield / Dilution | - | - | 0.23% | -0.23% | 0.24% | 0.21% |
Total Shareholder Return | 8.26% | 9.74% | 2.53% | 2.68% | 0.24% | 2.93% |